Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05971862
- Locations
- 🇰🇷
Yonsei University College of Medicine Severance Hospital, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Healthy Male Subjects
- Conditions
- Healthy Volunteers
- Interventions
- Drug: .[14C]-SKI-O-703
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT05042986
- Locations
- 🇺🇸
Labcorp Clinical Research Unit Inc., Madison, Wisconsin, United States
A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.
- First Posted Date
- 2019-08-15
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 163
- Registration Number
- NCT04057118
- Locations
- 🇺🇸
Oscotec Investigational Site (Site 3110), Beverly Hills, California, United States
🇺🇸Oscotec Investigational Site (Site 3105), Upland, California, United States
🇺🇸Oscotec Investigational (Site 3104), Miami Lakes, Florida, United States
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)
- Conditions
- Immune Thrombocytopenia
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT04056195
- Locations
- 🇺🇸
University of Southern California, 1441 Eastlake Ave., Los Angeles, California, United States
🇺🇸Duke University Medical Center, 2301 Erwin Road, Durham, North Carolina, United States
🇺🇸East Carolina University, 600 Moye Boulevard, Greenville, North Carolina, United States
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
- First Posted Date
- 2018-06-20
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT03564288
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Clinical Investigations Support Office (CISO), 1441 Eastlake Ave., Rm. 7327, Los Angeles, California, United States
🇺🇸Innovative Clinical Research Institute, Whittier, California, United States
- Prev
- 1
- 2
- Next